Directory
>
Daniel Erlanson
Daniel Erlanson
Chief Innovation Officer | Frontier Medicines
San Francisco, California, United States
Daniel Erlanson
Summary
Daniel Erlanson is a seasoned professional in the field of commercial physical research, currently serving as the Chief Innovation Officer at Frontier Medicines. With a strong academic background in Chemistry, including a PhD from Harvard University, Daniel has cultivated a robust career spanning over two decades in various roles, including VP of Chemistry and Senior VP of Innovation and Discovery. His leadership has been instrumental in driving innovation and discovery in the pharmaceutical sector. Daniel co-founded Carmot Therapeutics, showcasing his entrepreneurial spirit and commitment to advancing scientific research. He has a proven track record of long-term tenure in organizations, indicating a strong commitment to his roles. His experience in both startup and corporate settings enriches his perspective on innovation in the life sciences industry.
Daniel Erlanson
Work Experience
Chief Innovation Officer at
Frontier Medicines
January 2024 - Present
Senior VP of Innovation and Discovery at
Frontier Medicines
January 2022 - January 2024
VP of Chemistry at
Frontier Medicines
January 2019 - January 2022
Co-founder, Board Member, and VP of Chemistry at
Carmot Therapeutics
January 2008 - January 2019
Associate Director of Medicinal Chemistry at
Sunesis Pharmaceuticals, Inc.
January 2007 - January 2008
Senior Scientist at
Sunesis Pharmaceuticals, Inc.
January 2003 - January 2007
Staff Scientist at
Sunesis Pharmaceuticals, Inc.
January 2001 - January 2003
Scientist at
Sunesis Pharmaceuticals, Inc.
January 1999 - January 2001
NIH Postdoctoral Fellow at
Sunesis Pharmaceuticals, Inc.
January 1998 - January 1999
Postdoctoral Fellow at
Genentech
January 1997 - January 1998
Daniel Erlanson
Education
Harvard University, Phd
January 1997
Carleton College, Ba
Frequently Asked Questions about Daniel Erlanson
What is Daniel Erlanson email address?
Daniel Erlanson's primary email address is ***************@frontiermeds.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Daniel Erlanson work for?
Daniel Erlanson is a Chief Innovation Officer at Frontier Medicines, a company specializing in Commercial physical research.
Where Daniel Erlanson graduated from?
Daniel Erlanson holds a degree in Chemistry from Harvard University.
How can I directly contact Daniel Erlanson?
To contact Daniel Erlanson directly, you can use the email address ***************@frontiermeds.com. Complete contact information is available upon registration with Muraena.
Who is Daniel Erlanson?
Daniel Erlanson is a seasoned professional in the field of commercial physical research, currently serving as the Chief Innovation Officer at Frontier Medicines. With a strong academic background in Chemistry, including a PhD from Harvard University, Daniel has cultivated a robust career spanning over two decades in various roles, including VP of Chemistry and Senior VP of Innovation and Discovery. His leadership has been instrumental in driving innovation and discovery in the pharmaceutical sector. Daniel co-founded Carmot Therapeutics, showcasing his entrepreneurial spirit and commitment to advancing scientific research. He has a proven track record of long-term tenure in organizations, indicating a strong commitment to his roles. His experience in both startup and corporate settings enriches his perspective on innovation in the life sciences industry.
Daniel`s contact details
***************@frontiermeds.com
Colleagues
VP, Information Technology
Vice President, Head of Chemistry
Chief Of Staff
Co-director, Molecular Therapeutics Initiative
Vice President of DMPK
Co-Founder
Vice President Finance
Chief Science Officer
Chief Technology Officer
Senior Vice President, Strategy and Corporate Affairs